Mindfulness Training for Heart Failure
(MYH-II Trial)
Trial Summary
What is the purpose of this trial?
This projects studies the role of mindfulness training (MT) to improve self-care among patients with heart failure and cognitive impairment.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Mindfulness Training for Heart Failure?
Research shows that mindfulness training can help heart failure patients by reducing stress, improving cognitive function, and promoting better self-care. It has also been found to enhance medication adherence and improve symptoms like depression and fatigue, leading to a better quality of life.12345
Is mindfulness training safe for humans?
How is mindfulness training different from other treatments for heart failure?
Mindfulness training is unique because it focuses on improving cognitive function and self-awareness, which can help heart failure patients manage their condition better. Unlike traditional treatments that may focus on medication or physical interventions, mindfulness training aims to reduce stress and improve mental well-being, potentially enhancing medication adherence and self-care.12357
Research Team
Elena Salmoirago-Blotcher, MD, PhD
Principal Investigator
Cardiovascular Institute, The Miriam Hospital, Brown University
Eligibility Criteria
This trial is for adults over 18 with heart failure and mild cognitive issues who can speak English or Spanish. They must have a phone and not be planning to move during the study. People with severe mental health issues, enrolled in another study, or with very poor hearing or severe heart failure aren't eligible.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive phone-delivered mindfulness training (MT) sessions once a week for 8 weeks, integrated with daily guided individual practice, plus enhanced usual care (EUC)
Follow-up
Participants are monitored for cognitive function, psycho-behavioral factors, cardiac vagal control, and HF biomarkers at 3 and 9 months since baseline
Treatment Details
Interventions
- Enhanced Usual Care
- Mindfulness Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Miriam Hospital
Lead Sponsor
National Institute on Aging (NIA)
Collaborator